<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Occurrence of second <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e> (SHM) among 49,163 patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, who had been admitted to the National <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Center Hospital from 1962 to 1987, was investigated </plain></SENT>
<SENT sid="1" pm="."><plain>Forty-two cases of malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (38 non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 3 Hodgkin's diseases and 1 <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>) and 17 cases of <z:hpo ids='HP_0001909'>leukemias</z:hpo> (11 <z:hpo ids='HP_0002488'>acute leukemias</z:hpo>, 4 <z:hpo ids='HP_0005558'>chronic leukemias</z:hpo> and 2 <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>) developed as SHM </plain></SENT>
<SENT sid="2" pm="."><plain>Second malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were 1.37 times more frequent than expected (P less than 0.05), whereas no excess incidence was seen in second <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The incidence of malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> was 2.2 times higher than expected in patients with initial <z:hpo ids='HP_0012126'>stomach cancer</z:hpo> (P less than 0.01) </plain></SENT>
<SENT sid="4" pm="."><plain>Two-thirds of second non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> occurred in extranodal regions </plain></SENT>
<SENT sid="5" pm="."><plain>Nodal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were more prevalent in cases treated with chemotherapy and/or radiotherapy </plain></SENT>
<SENT sid="6" pm="."><plain>Second <z:hpo ids='HP_0001909'>leukemias</z:hpo> were <z:hpo ids='HP_0000001'>all</z:hpo> of myeloid origin except one case of <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Etiological <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of SHM is discussed in relation to treatment and other risk factors </plain></SENT>
</text></document>